Filter
618
Filtered Results: 618
Text search:
vaccine
candidates
Featured
Recommendations
76
New Publications
139
Language
Document type
No document type
235
Studies & Reports
128
Guidelines
105
Fact sheets
49
Strategic & Response Plan
32
Manuals
31
Resource Platforms
14
Situation Updates
8
Videos
7
Training Material
5
Online Courses
3
Brochures
1
Countries / Regions
Global
29
Congo, Democratic Republic of
21
India
18
Brazil
16
West and Central Africa
16
East and Southern Africa
12
Africa
12
Guinea
11
Nigeria
11
Latin America and the Carribbean
11
Liberia
10
Ethiopia
10
Germany
9
South Africa
9
Sierra Leone
8
Middle East and North Africa
8
Russia
8
Cameroon
7
Uganda
7
Kenya
7
Senegal
6
Haiti
6
Philippines
6
South Sudan
6
Ukraine
6
Western and Central Europe
6
Ghana
5
Zambia
5
Tanzania
5
Rwanda
5
Mozambique
5
Nepal
4
Syria
4
China
4
Indonesia
4
Benin
4
Angola
4
Madagascar
4
Burkina Faso
3
Guinea-Bissau
3
USA
3
Bangladesh
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Cambodia
2
Namibia
2
Colombia
2
Myanmar / Burma
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Zimbabwe
1
Somalia
1
Turkey
1
Thailand
1
Malawi
1
Central African Republic
1
Argentina
1
North Macedonia
1
Botswana
1
Mexico
1
Chile
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Asia
1
Venezuela
1
Eastern Europe
1
Italy
1
Albania
1
Timor Leste/ East Timor
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
67
Public Health
29
Key Resources
13
Pharmacy & Technologies
13
Women & Child Health
12
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
184
Ebola
47
Rapid Response
46
TB
41
NTDs
24
HIV
22
AMR
17
Health Financing Toolbox
12
Conflict
9
Caregiver
9
Planetary Health
9
Zika
8
Pharmacy
8
Mental Health
7
Global Health Education
7
Refugee
6
Polio
5
NCDs
4
Cholera
3
Natural Hazards
3
Disability
1
Typhoon
1
Specific Hazards
1
Cet article fait partie d’une série d’explications à propos de la mise au point et de la distribution des vaccins.
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 ... will be introduced.
For ease of use, the manual is available in a compiled form and in several separate modules that can be consulted individually. For each module, specific training material is also available to facilitate implementation.
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 ... methodology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented.
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailo...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB ... development and implementation, who include stakeholders involved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine<...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality...
An example of integration of research into epidemic response.
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guida...
Principles and Target Product Criteria. Roadmap January 12, 2015
Framework for Fair, Equitable and Timely Allocation of COVID-19 Vaccines in Africa. Highlights Day 1
The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document...
